 Todos Medical Ltd, together with its joint venture partner NLC Pharma Ltd., announced that it has forged an exclusive European licensing and distribution agreement with T-Cell Protect Hellas SA for a product based on its Tollovid and Tollovid Daily 3CL protease inhibitor and immune support dietary supplements. 